EDGAR Filing Documents for 0001670254-17-000251

Form C/A - Offering Statement: [Amend]

SEC Accession No. 0001670254-17-000251

Filing Date

2017-09-01

Accepted

2017-08-31 18:45:11

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	C/A
1		primary_doc.xml	C/A	10622
2		document_1.jpg	GRAPHIC	3136377
3		document_2.jpg	GRAPHIC	7593034
4		document_3.pdf	EX-99	7159664
5		document_4.pdf	EX-99	7159890
6		document_5.pdf	EX-99	1937022
7		document_6.pdf	EX-99	9800482
8		document_7.jpg	GRAPHIC	727942
9		document_8.jpg	GRAPHIC	1095119
10		document_9.pdf	EX-99	211927
11		document_10.pdf	EX-99	249040
12		document_11.pdf	EX-99	6128058
13		documents_list.htm	EX-99	223
	Complete submission text file	0001670254-17-000251.txt		60868936

Mailing Address 1756 BISON MEADOW LANE HEATH TX 75032

Business Address 1756 BISON MEADOW LANE HEATH TX 75032 2142932436

Bioclonetics Immunotherapeutics, Inc. (Filer) CIK: 0001701251 (see all company filings)